Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
UNIGENE LABORATORIES INC (UGNE)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-13 | Dec-31-12 | Sep-30-12 | Jun-30-12 | Mar-31-12 | Dec-31-11 | Sep-30-11 | Jun-30-11 |
| | 10-Q | 10-K | 10-Q | 10-Q/A | 10-Q | 10-K | 10-Q | 10-Q/A |
| Revenues |
| Product sales | | 0.4 | 2.0 | 1.3 | 0.6 | 1.3 | 1.3 | 0.6 |
| Licensing revenue | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 8.3 | 0.7 | 0.7 |
| Royalties | 0.1 | 0.0 | 0.2 | 0.1 | 0.3 | 0.4 | 0.3 | 0.4 |
| |
| Mix |
| Product sales | | 16.8% | 62.2% | 59.1% | 36.9% | 9.3% | 43.1% | 32.4% |
| Licensing revenue | 42.8% | 10.4% | 8.0% | 12.0% | 15.0% | 61.3% | 22.7% | 35.3% |
| Royalties | 13.8% | 1.1% | 5.1% | 6.7% | 19.9% | 2.8% | 10.2% | 20.3% |
| |
| Growth |
| Product sales | | -66.2% | 58.5% | 100.2% | -0.2% | -2.0% | 0.4% | -53.4% |
| Licensing revenue | 0.0% | -96.8% | -61.4% | -62.7% | -53.3% | 2189.2% | 117.5% | 125.5% |
| Royalties | -75.6% | -92.6% | -45.6% | -63.8% | -32.2% | -30.7% | -58.8% | -55.3% |
|